SAN FRANCISCO — Patients with non-alcoholic fatty liver disease carried a 91% higher risk for malignancy and the risk for cancer with obesity is “driven by NAFLD,” according to a presentation at The Liver Meeting 2018.
“The risk of malignancy was higher in NAFLD vs. controls ... 91% higher than the general population when we take all cancers into account,” Alina M. Allen, MD, of Mayo Clinic, Rochester, Minn., said during her presentation. “Obesity is associated with a higher risk of cancer only in those with NAFLD and not in those without.”
To read the full article, visit: Healio
A nuclear receptor links HIV drugs with liver disease
Physical activity linked to reduced risk of liver cancer
MICROB-PREDICT – €15 million EU funded microbiome research project kicks off